openPR Logo
Press release

Global Mirna Kits Market Size is Anticipated to reach US$ 8.76 Billion by 2034

06-19-2026 01:32 PM CET | Health & Medicine

Press release from: The Insight Parntners

Global Mirna Kits Market Size is Anticipated to reach US$ 8.76

The global MiRNA Kits Market is experiencing significant momentum as the demand for advanced molecular biology tools continues to rise across research institutes, diagnostic laboratories, and pharmaceutical companies. MicroRNA (miRNA) kits play a crucial role in isolating, quantifying, and analyzing small non-coding RNA molecules that regulate gene expression. These kits are increasingly being used in oncology research, infectious disease studies, and genetic disorder analysis, making them an essential component of modern life sciences.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00012136?utm_source=OpenPR&utm_medium=10770

The global MiRNA Kits Market size is projected to reach US$ 8.76 Billion by 2034 from US$ 1.95 Billion in 2025. The market is anticipated to register a CAGR of 17.4% during the forecast period 2026-2034. The MiRNA Kits Market dynamics are strongly influenced by increasing investments in genomic research, rising prevalence of chronic diseases such as cancer, and expanding applications of miRNA profiling in drug discovery and personalized medicine. Additionally, technological advancements in automated RNA extraction systems and the growing adoption of high-throughput sequencing technologies are enhancing efficiency and accuracy in miRNA-based studies.

What Are the Key Drivers Influencing the Growth of the MiRNA Kits Market?

The growth of the MiRNA Kits Market is primarily driven by the rapid expansion of molecular diagnostics and the increasing importance of non-coding RNA research in understanding disease mechanisms. miRNA molecules are now recognized as critical biomarkers for early disease detection, especially in cancer and neurological disorders. Pharmaceutical and biotechnology companies are investing heavily in miRNA-based therapeutic development, which is further boosting demand for reliable and efficient miRNA extraction kits.

Another major driver is the rising adoption of personalized medicine approaches, where patient-specific genetic information is used to tailor treatment strategies. MiRNA profiling is becoming an essential tool in identifying disease progression and treatment response, thereby improving clinical outcomes. Moreover, government funding and private investments in genomics and proteomics research are supporting the widespread use of advanced miRNA technologies in academic and clinical settings.

How Is Technological Innovation Transforming the MiRNA Kits Market Landscape?

Technological innovation is playing a pivotal role in reshaping the MiRNA Kits Market, particularly through the integration of automation, artificial intelligence, and next-generation sequencing (NGS) technologies. Automated miRNA extraction systems are significantly reducing manual errors, improving reproducibility, and increasing processing speed in laboratories.

Furthermore, advancements in kit design have improved sensitivity and specificity, allowing researchers to detect even low-abundance miRNA molecules. The development of multiplexing capabilities has also enabled simultaneous analysis of multiple miRNA targets, enhancing research efficiency. These innovations are not only improving laboratory workflows but are also reducing operational costs, making miRNA analysis more accessible to mid-sized research facilities and diagnostic centers.

Explore full report: https://www.theinsightpartners.com/reports/mirna-kits-market

What Opportunities Exist for Market Expansion in Emerging Regions?

Emerging economies present substantial growth opportunities for the MiRNA Kits Market due to increasing investments in healthcare infrastructure and rising awareness of genomic research applications. Countries in the Asia Pacific and Latin America are witnessing rapid expansion in biotechnology research hubs, supported by government initiatives and international collaborations.

Additionally, the growing prevalence of cancer and infectious diseases in these regions is driving demand for advanced diagnostic tools, including miRNA-based assays. The expansion of contract research organizations (CROs) and academic research institutions is further contributing to market penetration. As cost-effective diagnostic solutions become more widely available, the adoption rate of miRNA kits is expected to accelerate significantly in developing regions.

Key Players in the MiRNA Kits Market
• Thermo Fisher Scientific Inc.
• QIAGEN N.V.
• Bio-Rad Laboratories, Inc.
• Takara Bio Inc.
• New England Biolabs
• Illumina, Inc.
• Agilent Technologies, Inc.
• Roche Diagnostics
• Promega Corporation
• System Biosciences LLC

Purchase a Copy of this report: https://www.theinsightpartners.com/buy/TIPRE00012136?utm_source=OpenPR&utm_medium=10770

Future Outlook of the MiRNA Kits Market

The future of the MiRNA Kits Market is expected to be shaped by continued advancements in genomics, increasing integration of digital technologies in laboratory workflows, and expanding applications in precision medicine. As research into microRNA deepens, its role in disease diagnostics, prognostics, and therapeutic development will become even more prominent. The growing shift toward personalized healthcare, coupled with rising demand for early disease detection tools, will continue to drive strong market growth over the forecast period.

In addition, the increasing collaboration between biotech companies and academic institutions is likely to foster innovation in miRNA extraction and analysis technologies. With continuous improvements in automation and sequencing platforms, the market is expected to move toward higher efficiency, scalability, and cost-effectiveness.

Related Reports:
Bioprocessing Market- https://www.theinsightpartners.com/reports/bioprocessing-market

Epigenetics Market- https://www.theinsightpartners.com/reports/epigenetics-market

Contact Us

Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us

The Insight Partners is a leading provider of actionable market intelligence and consulting services across various industries. Our research reports combine advanced analytics, expert insights, and reliable data to help organizations identify new opportunities, optimize strategies, and achieve sustainable growth. We specialize in delivering in-depth market studies covering healthcare, technology, manufacturing, and emerging sectors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Mirna Kits Market Size is Anticipated to reach US$ 8.76 Billion by 2034 here

News-ID: 4555109 • Views:

More Releases from The Insight Parntners

Live Cell Shipper Market to Reach Significant Valuation by 2034, Driven by Rising Demand for Advanced Biologics Logistics, According to The Insight Partners
Live Cell Shipper Market to Reach Significant Valuation by 2034, Driven by Risin …
The Live Cell Shipper Market is witnessing significant transformation as advancements in biotechnology, regenerative medicine, and cell and gene therapies continue to expand globally. Live cell shipping solutions are essential for maintaining the viability of biological samples, including living cells, tissues, and clinical materials, during transportation across research institutes, pharmaceutical companies, and diagnostic laboratories. The increasing demand for temperature-controlled and cryogenic logistics has positioned the Live Cell Shipper Market as
Bio-Electronics Market to Reach US$ 33.16 Billion by 2034, Growing from US$ 14.34 Billion in 2025 at a CAGR of 9.76%, Driven by Rising Demand for Implantable Devices, Wearable Health Monitoring Systems, and Integration of Electronics with Biological Syste
Bio-Electronics Market to Reach US$ 33.16 Billion by 2034, Growing from US$ 14.3 …
The global Bio-Electronics Market is witnessing significant transformation, driven by the convergence of biotechnology, electronics, and medical sciences. Bio-electronics refers to the integration of biological systems with electronic devices to monitor, diagnose, and treat medical conditions more effectively. These technologies are increasingly being adopted in applications such as implantable devices, wearable health monitors, neural implants, and regenerative medicine solutions. With the rising prevalence of chronic diseases, aging populations, and increasing
Organoids Market to Grow Rapidly by 2031 Driven by 3D Cell Culture and Drug Discovery Advances
Organoids Market to Grow Rapidly by 2031 Driven by 3D Cell Culture and Drug Disc …
The Organoids Market is experiencing significant expansion due to its rising adoption in biomedical research, regenerative medicine, and drug discovery applications. Organoids, which are miniature and simplified versions of organs grown in vitro, have revolutionized preclinical testing by providing more accurate human tissue models compared to traditional 2D cell cultures. Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00017616?utm_source=OpenPR&utm_medium=10770 The global Organoids Market size is projected to reach US$ 15.01 billion by 2031 from US$ 3.03
Uveitis Treatment Market Size to Hit US$ 4.71 Billion by 2034, Driven by Expanding Access to Innovative Ophthalmic Treatments, According to The Insight Partners
Uveitis Treatment Market Size to Hit US$ 4.71 Billion by 2034, Driven by Expandi …
The uveitis treatment market is experiencing significant growth as the prevalence of inflammatory eye diseases continues to increase globally. Uveitis refers to inflammation of the uvea, the middle layer of the eye, and can lead to severe vision impairment or blindness if left untreated. Growing awareness regarding early diagnosis, increasing access to advanced ophthalmic care, and continuous innovation in biologic therapies and corticosteroid treatments are contributing to the expansion of

All 5 Releases


More Releases for RNA

Small Interfering RNA (siRNA) Therapeutics Market Growth (2026-2033) | RNA Drugs …
DataM Intelligence has released a new research report titled "Small Interfering RNA (siRNA) Therapeutics Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - • 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? • The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. • Expected exponential
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a